Endothelium-dependent constriction in mouse pial arterioles was demonstrated by testing contractile responses before and after endothelial injury. All responses were monitored at the same site as the injury. Injury was produced in vivo by exposing an arteriole on the brain surface to the beam of a 6-mW helium-neon laser after first sensitizing the micro vascular bed to the laser energy by injecting Evans blue intravenously. The contractile response to serotonin creatinine sulfate (20 /tg/ml) and to sodium arachidonate (30 /ig/ml) was monitored in vivo with an Image splitter and TV microscope. The responses before laser injury were always constriction; the responses after laser injury were always relaxation. After laser injury, acetykholine chloride (80 /ig/ml) constricted every vessel tested at the injured site. Thus, the injured segment had not lost the capacity to constrict even though neither serotonin nor arachidonate remained able to induce a constriction. The endothelium-dependent constrictions to serotonin or arachidonate were also blocked by pretreatment of the mouse with cyclooxygenase inhibitors, acetylsaUcylic acid (100 mg/kg i.p.) or indomethacin (5 mg/kg). The data suggests that endothelium-dependent constriction to serotonin is mediated by release of arachidonate from the endothelial cell and conversion of that arachidonate by cyclooxygenase to some constricting prostanoid. (Circulation Research 1988;63:837-843) 
T he study of vascular physiology has been greatly altered by the relatively recent discovery that endothelial cell products mediate dilation by many agonists.'- 3 The agonists involved differ somewhat depending on animal species and on the particular vascular bed within a species.'- 5 The number and nature of the endothelium-derived relaxing factors that actually control the dilations in question have not yet been resolved. 6 -' 2 The existence of endotheliumdependent constriction has also been reported but in relatively few investigations. n~22 The evidence for both endothelium-dependent constriction and dilation was originally based on in vitro studies of large vessels. A major method used to establish the existence of these phenomena has been to destroy a portion of the endothelial cells and to demonstrate altered relaxation or constriction to selected agonists while the effects of other agonists remained unaffected.'- 3 More recently, techniques were developed that injure microvascular endothelium in situ and in vivo. When arterioles on the brain surface (pial arterioles) were injured in this manner, the injury was followed by loss of response to acetylcholine and bradykinin, 2324 dilators whose action in large vessels in vitro was already established to be endothelium-dependent. '- 3 Moreover, relaxation by nitroprusside or papaverine remained unaltered. The latter were already established as dilators acting directly on vascular smooth muscle without dependence on interaction of agonist with endothelium. 1 -3 One of the techniques 24 of injuring microvascular endothelium in situ and in vivo has been used in the present study to determine whether endothelial damage eliminated the response of pial arterioles to either serotonin or sodium arachidonate. As in previous studies, mice were used. 23 -24 In these animals, pial arterioles normally constrict to serotonin or arachidonate, 2526 a result that differs from that reported in some but not all studies of other species. l0 -27 - 28 Our results will show that constriction is converted to dilation by the endothelial injury. The disappearance of constriction was not attributable to damage of smooth muscle because acetylcholine was able to constrict the same vessels-this constriction was the result of acetylcholine's (ACh) direct muscarinic action on vascular smooth muscle when endothelium-dependent dilation by ACh has been eliminated.'- 3 We also report the reversal of constriction by blockade of cyclooxygenase, thereby implicating a prostanoid as mediator of the endotheliumndependent constriction to both arachidonate and serotonin.
Materials and Methods
Male mice (ICR strain; Dominion Labs, Dublin, Virginia) were anesthetized with urethane, and the pial arterioles were exposed by craniotomy as previously described. 29 -31 The body temperature was maintained at 37° C. The cerebral surface was continuously suffused at 1 ml/min with artificial cerebrospinal fluid 32 at pH 7.34 ±0.01 (mean + SEM). 30 An arteriole (diameter, 30-40 fim) was arbitrarily selected for observation through a Leitz microscope (Rockleigh, New Jersey). The microscopic field was illuminated from the side by a halogen lamp and fiber-optic guide. The microscope was fitted with the objective lens turret of a Leitz metallurgic illuminator; the metallurgic illuminator itself was disconnected from the turret and not used. Removal of the illuminator exposed a side port on the turret at right angles to the objective.
The technique for injuring the vessel was modified from that introduced by Kovacs et al 33 so that a less-severe injury was obtained. We have described our modification and its use extensively in earlier publications. 24 The beam of a 6-mW helium-neon laser (Spectra Physics, Mountainview, California) was directed through the side port and downward through the objective lens by the optics within the turret. Thus, the laser beam epi-iliuminated its target and appeared as a red dot. Infinity-corrected objectives were used. The beam was 18 ^m in diameter with a x 20 objective and 36 fim in diameter with a x 10 objective. The 6-mW intensity of the laser beam was confirmed with a silicon diode detector (United Detector, Santa Monica, California). The calculated energy delivered at a spot 18 /i,m in diameter was 2 x 10 9 /iW/cm 2 . The vessel was sensitized to the laser by intravenous Evans blue (2% solution in normal saline, 1 ml/100 g body wt) given 30 minutes before the start of the study. The dye rapidly binds to albumin and continues to circulate. A x 10 objective was used in this set of studies. TV microscopy was used to monitor the vascular bed, and diameters were measured with an imageshearing device to shear the image of the vessel on the TV monitor at a total magnification of x 750. 34 Output from the image splitter was recorded on a strip chart for a permanent record of the responses. Changes of less than 0.5 pm can be reliably detected. 35 The presence of circulating Evans blue sensitized vessels even to light from the 150-W halogen lamp so that there was frequent vasoparalysis, failure to respond to vasoactive agents, or subsequent application of the laser resulted in formation of a focal narrowing ("waist") at the site of laser injury. Two maneuvers were required to eliminate the toxic effects of light from the halogen lamp in the Evans blue-sensitized bed. First, the light was drastically reduced with an iris diaphragm. Second, the reduced light intensity was used only when monitoring the vessel and was turned off during "rest" periods between observations. An image-intensified silicon TV tube and SIT camera were required to obtain adequate images with the image splitter and TV monitor at the low levels of halogen illumination. A Dage-MTI (Michigan City, Indiana) Model 66 camera with a 737058-01 silicon tube was used.
An increased toxicity of the laser was noted in preliminary studies when the suffusate of artificial cerebrospinal fluid crossing the craniotomy site was maintained at 37° C. Therefore, the temperature of the suffusate was reduced to 23° C. At the higher temperature, many arterioles displayed narrowing at the site of laser damage. At the lower temperature, this occurred in only 10% of the mice, which were discarded without further study. This observation of greater toxic effects at higher temperatures may support the opinion of those who originally devised the laser-Evans blue technique that endothelial damage was heat mediated (laser "burn" with light absorbed and heat generated by the dye). 33 If exposure to the laser is sufficiently long, platelet aggregation is initiated at the site of injury. 3336 The object was to stop the injury before platelet aggregation was initiated, thereby observing the effects of endothelial damage on vascular responsiveness without the complicating action of substances released by aggregating platelets. This was accomplished by reducing the duration of exposure to the laser to 20 seconds.
After craniotomy, mice were injected with Evans blue, and the suffusate of mock cerebrospinal fluid was started over the craniotomy site. The pial surface was suffused for 30 minutes to achieve equilibrium and steady baseline diameters. Then, the first application of either sodium arachidonate (30 pgl nil) or serotonin creatinine sulfate (20 Aig/rnl) was made. These drugs, as well as the ACh used later in the experiment, were dissolved in mock cerebrospinal fluid with pH and temperature adjusted to the same values (7.35 and 23° C) as the regular suffusate. The drugs were administered by interrupting the normal suffusate with a 1-ml bolus given over a 60-second period. Arteriolar diameter was monitored with the TV microscope and image splitter before, during, and after administration of the drug. Diameter changes began within seconds of administration and reached a peak within 1 minute after the application was finished. Within the next minute, the arteriole began to return to baseline diameter under the influence of the normal suffusate of mock cerebrospinal fluid. The maximal change in diameter produced by the drug bolus was used to calcu-late the effect of the agonist. The new diameter was expressed as a percent of the baseline diameter. Thus, a relaxation from 30 to 33 fim was called 110%. Five minutes after the initial exposure to a drug, the arteriole was injured by a 20-second exposure to the laser at the same site as that monitored previously. Baseline diameter was monitored; after 15 minutes, two additional responses were monitored at the same site, 15 minutes apart with washout in between. These post-laser responses were responses to the original agonist (serotonin or arachidonate) and to ACh (80 figlml). The order of these last two tests was randomized, so in some mice ACh was tested immediately after laser injury, and in an equal number of mice serotonin or arachidonate was given immediately after laser injury.
The ACh served three purposes. The normal response to ACh is relaxation. This is converted to constriction by endothelial damage. 1224 Thus, constriction produced by ACh would confirm that endothelial damage had been produced by laser-Evans blue. The constriction would also show that the arteriole was still capable of constricting at the site of laser damage and would serve as a "time control" showing that preparation failure over time was not responsible for elimination of the contractile response to serotonin or arachidonate after exposure to the laser.
An additional time control was also used. This was the administration of the original agonist, serotonin or arachidonate, to every mouse 1 hour after the laser injury. The same arteriole was monitored but this time at a site 100 (xm away from the original site. This test would show whether, even after a much longer passage of time, the arteriole was still capable of responding normally at an undamaged site.
We studied not only the effect of laser injury but also the effect of cyclooxygenase inhibitors. We used acetylsalicylic acid (ASA; 100 mg/kg) or indomethacin (5 mg/kg). The inhibitor, in phosphate buffer pH 8, was injected intraperitoneally approximately 10 minutes before anesthesia and craniotomy. After craniotomy, the suffusate of mock cerebrospinal fluid was started. One hour after injection of the ASA or indomethacin, baseline diameter was determined, followed by measurement of the response to either serotonin or arachidonate. Two separate ASA studies were conducted: one with serotonin and one with arachidonate. There were 10 mice in each study. This design was repeated with indomethacin. Finally, an additional study was performed in which serotonin was applied before ASA injection. The response to serotonin was monitored, and ASA (100 mg/kg i.p.) was injected. Thirty minutes later, the response to serotonin was again determined. In all of these studies with cyclooxygenase inhibition, the suffusate temperature was 23° C and Evans blue was injected intravenously 30 minutes before the first test of arteriolar response. Thus, the conditions existing in the laser studies were duplicated in the studies of cyclooxygenase inhibitors.
The serotonin creatinine sulfate and ACh were obtained from Sigma Chemical, St. Louis, Missouri, and the sodium arachidonate was obtained from Nuchek (99% pure; Elysium, Minnesota). Solutions of serotonin were made fresh each day. Sodium arachidonate was kept as a stock solution of 1 mg/ml in deionized water and kept under liquid nitrogen at -80° C. Solutions of 30 /tg/ml in mock cerebrospinal fluid were made daily from this stock. Aspirin (sodium salicylate USP, Fisher) and indomethacin (Merck) were made daily in phosphate buffer pH 8 for injection intraperitoneally. Preliminary experiments showed that buffer alone had no effect on responses to arachidonate or serotonin. At the end of each experiment, blood from the carotid artery was obtained for O 2 , CO 2 , and pH measurements in an ultramicro blood gas analyzer (Radiometer, Cleveland, Ohio). These values were obtained as a guide to the condition of the animals and were approximately the same from study to study. The mean±SD for all studies were CO 2 = 30±4, O ? =107±7, and pH = 7.33±0.05. (These values will not be referred to again.)
Results

Effect of Laser-Evans Blue Injury on Response to Serotonin
In each of 10 mice, serotonin creatinine sulfate (20 fig /ml ) constricted pial arterioles before injury. In every case, after injury, the arteriole responded to serotonin by relaxing. This reversal of effect was highly significant (p<0.01 by Wilcoxon test 37 ; Table  1 ). As shown in Table 1 , baseline diameter was unaffected by the laser. Although incapable of constricting to serotonin after endothelial injury, the arterioles were still capable of constricting to another stimulus. This was shown by testing the response to ACh. The normal response to ACh is relaxati >n, but because of loss of an endothelium-dependant relaxing factor, this is converted to a constricting response by laser-Evans blue injury. 1224 In each mouse, the injured arteriole, incapable of constricting to serotonin, was still constricted by 80 /ig/ml ACh. The average constriction was 3 ± 2 % (mean±SD). This constriction, though small, was not a result of random noise, which would have resulted in constriction only half the time rather than every time (p<0.03 by Fisher test of exact probability 37 ). Moreover, the post-laser-constricting responses to ACh were markedly different from the post-laser-relaxing responses in the same arterioles (p<0.01 by Wilcoxon test). Finally, as further evidence that the vessels had not lost the ability to constrict simply because of the passage of time, we monitored the response to serotonin 1 hour after laser injury at a site 100 /xm away from the injured site. The arterioles constricted in every case (mean diameter, 95 ±3% of baseline).
Effect of Laser-Evans Blue Injury on Response to Sodium Arachidonate
In each mouse, sodium arachidonate (30 /ig/ml) constricted arterioles before injury and relaxed the same arterioles after injury (/><0.01 by Wilcoxon test; Table 2 ). As shown in Table 2 , the diameter of the arterioles was not changed by the injury. After endothelial injury, the arterioles were still capable of constricting as shown by the response to ACh. The average constriction to ACh was 4 ± 1 % (mean±SD), and each of the 10 arterioles constricted. Because these constrictions occurred in all 10 cases, they were significantly different in frequency from the 50% frequency expected from random alterations in diameter (p<0.03 by Fisher test 37 ). The post-laser-constricting responses to ACh were also significantly different from the postlaser-dilating responses to arachidonate in the same arterioles (p<0.01 by WUcoxon test). The constriction by ACh verified that endothelial injury had occurred and established that the vascular smooth muscle was still capable of constricting. As further evidence that the arterioles had not lost their ability to constrict simply because of the passage of time, we monitored the response to arachidonate 1 hour after laser injury at a site 100 /im away from the injured site. The arterioles constricted in every case (mean diameter, 96±2% of baseline).
Effect of Cyclooxygenase Inhibitors on Response to Serotonin and Arachidonate
A total of five studies were performed, each with 10 mice.
One hour after 100 mg/kg i.p. ASA was administered, each mouse displayed relaxation of arterioles (diameter, 32 ±3 /im) by serotonin creatinine sulfate (20 /xg/ml). Dilation averaged 106 ±2% (mean ± SD) of baseline diameter. This is in marked contrast to the constrictions that followed application of serotonin to vessels of every control mouse in the previous portion of this study.
To confirm the control data, we tested the effect of serotonin before as well as after ASA treatment on 10 additional mice. Before treatment, every arteriole (diameter, 32 ±3 fim; mean±SD) constricted to serotonin (diameter, 96 ±2% of baseline; mean±SD), while 30 minutes after ASA, each of the arterioles dilated. Dilation averaged 104±l% (mean±SD) of baseline. The difference between constriction before ASA and dilation after ASA was highly significant (p<0.01 by Wilcoxon test).
When mice were tested 1 hour after injection with indomethacin (5 mg/kg i.p.) rather than with ASA, their arterioles again responded to serotonin only by dilating. Ten mice were tested; baseline diameter of arterioles was 33 ± 3 /xm (mean ± SD) and dilation averaged 105 ±3% (mean ± SD) of baseline diameter.
The normal constricting response produced by sodium arachidonate in mouse pial arterioles was also changed to relaxation by treatment with ASA (100 mg/kg i.p.) or indomethacin (5 g/kg i.p.). After ASA, arterioles 31 ± 1 fim in diameter were relaxed to 106 ±3% (mean±SD) of diameter by 30 /tg/ml sodium arachidonate. Every arteriole dilated.
In 10 separate mice treated with indomethacin, every arteriole was also dilated by sodium arachidonate. Baseline diameter was 32 ± 3 fim (mean ± SD), and relaxed arterioles averaged 102 ± 1 % of that diameter. While very small, these dilations were real. Random changes in size would be expected to cause relaxation only 50% of the time, while in our case, every arteriole relaxed (/?<0.03, compared with chance frequency by Fisher test).
Discussion
There are two significant new findings. First, injury by helium-neon laser-Evans blue treatment reverses the normal response of mouse pial arterioles to both serotonin and sodium arachidonate. The normal responses in this preparation are constriction. 2526 After injury relaxation was produced by these two agents. Second, the normal constriction is inhibited by cyclooxygenase inhibitors, suggesting that the constriction was mediated by a cyclooxygenase product.
Laser-Evans blue is known to injure microvascular endothelium in situ 33 -36 and to eliminate the response of mouse pial arterioles to endotheliumdependent dilators like acetylcholine and bradykinin. 24 It is reasonable to suggest that the same injury has eliminated constriction by serotonin and arachidonate because, in this species and vascular bed, these agents produce endothelium-dependent constriction. We know that constriction was not eliminated as a consequence of smooth muscle injury because in each vessel acetylcholine was still able to constrict the vessels. The latter response is a result of direct stimulation of muscarinic receptors on the vascular smooth muscle. 1223 - 24 The fact that ACh constricted artenoles at the site of laser injury also attests to the existence of endothelial injury because ACh relaxes arterioles with normal endothelium. 2324 The constrictions produced by ACh at the site of laser injury were small but were seen in every injured vessel. Their small size may reflect the fact that the constricting action of ACh on smooth muscle was partially counteracted by residual production of an endothelium-dependent relaxing factor elicited by ACh at or adjacent to the same site.
The contractile responses to ACh show that after the laser, the contractile responses to serotonin and arachidonate were not lost simply because of fatigue or deterioration of the preparation. Further evidence against the operation of fatigue was provided by additional applications of serotonin or arachidonate, at least 30 minutes after the application of ACh. These final applications of serotonin or arachidonate showed that in every case the uninjured segment of the arteriole was still constricted by either serotonin or arachidonate, even though an hour had elapsed since the initial, prelaser application of the agonist. These final constrictions were slightly smaller than the original constrictions. This might reflect a very small effect of fatigue or deterioration of the preparation, which can in no way explain either the total failure of serotonin or arachidonate to constrict arterioles immediately after laser injury or the production at that time of dilation instead of the normal constriction.
While much recent attention has been paid to endothelial mediation of relaxation,'-3 there have been very few reports of endothelium-mediated vasoconstriction. Hypoxia has produced endotheliumdependent constriction of several large arteries or veins in vitro. 419 Arachidonate is reported to induce endothelium-dependent augmentation of contractile responses to norepinephrine 4 and to produce both endothelium-dependent relaxation and constriction of large arteries in vitro. 15 Endothelium-dependent constriction of large veins was also observed. 13 As in the present study, these venous constrictions were also cyclooxygenase-dependent. 13 In canine basilar artery, norepinephrine in vitro produced cyclooxygenase and endothelium-dependent constriction 2122 reminiscent of the serotonergic and arachidonate effects we reported. However, in brain vessels of other species, norepinephrine was found to produce endothelium-dependent dilation rather than a constriction. 38 Serotonin has generally been found to produce an endothelium-dependent relaxing effect that counters a direct constricting action of serotonin on vascular smooth muscle. However, the net effect of the opposing forces is usually constriction. 39 -40 Nevertheless, serotonin, in concentrations of 3 x 10~6 M or greater, has been reported to cause endotheliumdependent constriction in coronary arteries of normal pigs and thoracic aortic rings of hypertensive rats. 1741 In larger cerebral arteries, elevated intramural pressure has been reported to produce endothelium-mediated increases in tone, 20 and this effect may be mediated by a serotonin-sensitive ion channel. 42 Serotonin's constricting effect was converted to relaxation by cyclooxygenase inhibition as well as by endothelial injury. This suggests that constriction by serotonin is mediated by endothelium via some product of cyclooxygenase. Prostaglandin F 2o is a likely candidate because this prostaglandin constricts pial arterioles in our preparation. 30 However, without additional studies, other mediators such as thromboxane cannot be ruled out. Thromboxane has been implicated as the endothelialderived mediator of arachidonate-stimulated constriction of canine basilar artery. 21 -22 We used arachidonate, the substrate for cyclooxygenase, to test the hypothesis of cyclooxygenasedependent, endothelium-dependent constriction in mouse pial arterioles. Both endothelial injury and cyclooxygenase inhibition converted constriction to dilation. This supports the hypothesis that serotonin causes endothelium to release arachidonate and produce a constriction via the action of cyclooxygenase on the arachidonate. We did not investigate the means by which serotonin may release endogenous arachidonate.
Because both serotonin and arachidonate also produced small but constant dilations after endothelial injury or after inhibition of cyclooxygenase, we suggest that the smooth muscle of pial arterioles may produce a dilator from arachidonate without the action of cyclooxygenase on that substrate. Serotonin would then stimulate this chain of events if endothelium were injured. We have not tested these hypotheses, so the mechanism(s) of relaxation after endothelial injury of mouse pial arterioles remains speculative.
In previous studies of this preparation, blockade of serotonin by an S 2 -receptor blocker inhibited but did not reverse serotonin's action. 25 In cats, constriction of pial arterioles by serotonin was blocked but not reversed by inhibition with an S 2 -receptor blocker. 28 However, in rat mesenteric arterioles, constriction was inhibited by S 2 -receptor blockade and dilation was then unmasked. 18 In previous studies in our laboratory, cyclooxygenase inhibitors blocked but did not reverse the constricting action of arachidonate on mouse pial arterioles. 26 In a variety of preparations including pial arterioles of other species, arachidonate relaxed pial arterioles. 10 Serotonin has been reported to not only constrict pial arterioles in diverse species 23 -28 but also to relax pial arterioles in one of the same species. 27 We may reconcile these diverse results from the same and different laboratories not only by considering the possibility of species differences, where appropriate, but also by suggesting the presence of a different balance of constricting and dilating mediators in the different studies. It is only recently that the true complexity of vasoactive responses has been revealed. The possibility now exists for opposing simultaneous actions of dilating and constricting forces, some of which are endothelium-dependent but all of which are set in motion by a single agonist like serotonin or arachidonate. In some instances, different results might then be explained by endothelial capacities to produce or release vasoactive mediators. This might or might not reflect a degree of otherwise undetectable endothelial malfunction in a given series of animals. Unfortunately, there is as yet no independent means of evaluating this type of endothelial integrity because even ultrastructural morphology may be normal when endothelial mediation of tone is impaired. 23 -24 Moreover, we have no functional definition of "normal." Are pial arterioles that favor either dilation 27 or constriction 28 by serotonin normal, or would an equal balance of opposing forces leading to no change in diameter be the truly normal response? At present, there seems to be no way to answer these questions. One can merely report results in a particular species and vascular bed while carefully describing the conditions of the experiment.
The responses to serotonin and arachidonate in this study were small. Nevertheless, their effect on flow would be significant if they occurred throughout the cerebral vascular bed because resistance is inversely related to the third or fourth power of the radius. However, more important than the magnitude of the effects shown here are the new mechanisms for regulating the tone of brain arterioles as revealed by the data, that is, the existence of endothelium-and cyclooxygenase-dependent constriction to serotonin and arachidonate, at least in mice, and the existence of an opposing dilating pathway triggered by the same agonists but independent of endothelium or the action of cyclooxygenase. Moreover, this knowledge was obtained through in vivo study of microvessels rather than by the in vitro study of larger vessels that usually provide information concerning the endothelium-dependent mechanisms that can regulate vascular tone.
